Hellman Tapio, Kiviniemi Tuomas, Vasankari Tuija, Nuotio Ilpo, Biancari Fausto, Bah Aissa, Hartikainen Juha, Mäkäräinen Marianne, Airaksinen K E Juhani
Department of Medicine, Turku University Hospital and University of Turku, Hämeentie 11, PO Box 52, 20521, Turku, Finland.
Heart Center, Turku University Hospital and University of Turku, Hämeentie 11, PO Box 52, 20521, Turku, Finland.
BMC Cardiovasc Disord. 2017 Jan 18;17(1):33. doi: 10.1186/s12872-017-0470-0.
Elective cardioversion (ECV) of atrial fibrillation (AF) is a standard procedure to restore sinus rhythm. However, predictors for ineffective ECV (failure of ECV or recurrence of AF within 30 days) are unknown.
We investigated 1998 ECVs performed for AF lasting >48 h in 1,342 patients in a retrospective multi-center study. Follow-up data were collected from 30 days after ECV.
Median number of cardioversions was one per patient with a range of 1-10. Altogether 303/1998 (15.2%) ECVs failed. Long (>5 years) AF history and over 30 days duration of the index AF episode were independent predictors for ECV failure and low (<60/min) ventricular rate of AF predicted success of ECV. In patients with successful ECVs an early recurrence of AF was detected in 549 (32.4%) cases. Female gender, high (>60/min) ventricular rate, renal failure and antiarrhythmic agents at discharge were the independent predictors for recurrence. In total ECV was ineffective in 852 (42.6%) cases. Female gender (OR 1.44, CI95% 1.15-1.80, p < 0.01), young (<65 years) age (OR 1.31, CI95% 1.07-1.62, p = 0.01), ventricular rate >60/min (OR 1.92, CI95% 1.08-3.41, p = 0.03), antiarrhythmic medication at discharge (OR 1.48, CI95% 1.14-1.93, p < 0.01) and low (<60/ml/min) estimated glomerular filtration rate (OR 1.59, CI95% 1.08-2.33, p = 0.02) were predictors of ineffective ECV.
Female gender, use of antiarrhythmic drug therapy and renal failure predicted both recurrence of AF and the composite end point. For the first time in a large real-life study several clinical predictors for clinically ineffective ECV were identified.
心房颤动(AF)的择期心脏复律(ECV)是恢复窦性心律的标准操作。然而,无效ECV(ECV失败或30天内AF复发)的预测因素尚不清楚。
我们在一项回顾性多中心研究中调查了1342例患者中1998次针对持续时间超过48小时的AF进行的ECV。从ECV后30天收集随访数据。
每位患者的心脏复律中位数为1次,范围为1至10次。总共303/1998(15.2%)次ECV失败。长期(>5年)AF病史和本次AF发作持续超过30天是ECV失败的独立预测因素,而AF的心室率低(<60次/分钟)预示着ECV成功。在ECV成功的患者中,549例(32.4%)检测到AF早期复发。女性、心室率高(>60次/分钟)、肾衰竭和出院时使用抗心律失常药物是复发的独立预测因素。总体而言,852例(42.6%)患者的ECV无效。女性(OR 1.44,CI95% 1.15 - 1.80,p < 0.01)、年轻(<65岁)(OR 1.31,CI95% 1.07 - 1.62,p = 0.01)、心室率>60次/分钟(OR 1.92,CI95% 1.08 - 3.41,p = 0.03)、出院时使用抗心律失常药物(OR 1.48,CI95% 1.14 - 1.93,p < 0.01)和估计肾小球滤过率低(<60毫升/分钟)(OR 1.59,CI95% 1.08 - 2.33,p = 0.02)是无效ECV的预测因素。
女性、使用抗心律失常药物治疗和肾衰竭是AF复发和复合终点的预测因素。在一项大型现实生活研究中首次确定了几个临床上无效ECV的临床预测因素。